EyeGate Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/09/2024 | Q2 2024 | -$0.53 | $20,000 | |||
| 11/15/2021 | Q3 2021 | -$0.42 | $0 | |||
| 08/12/2021 | Q2 2021 | -$0.42 | -$0.35 | 0.07 | $0 | |
| 05/12/2021 | Q1 2021 | -$0.38 | -$0.37 | 0.01 | $0 | |
| 03/25/2021 | Q4 2020 | -$0.44 | -$0.53 | -0.09 | $12,059 | |
| 11/09/2020 | Q3 2020 | -$0.42 | -$0.44 | -0.02 | $0 | |
| 08/06/2020 | Q2 2020 | -$0.43 | -$0.38 | 0.05 | $0 | |
| 05/06/2020 | Q1 2020 | -$0.43 | $0 | |||
| 03/04/2020 | Q4 2019 | -$0.81 | -$0.91 | -0.1 | $0 | |
| 11/07/2019 | Q3 2019 | -$1.15 | $0 | |||
| 08/08/2019 | Q2 2019 | -$0.75 | -$0.63 | 0.12 | $0 | |
| 05/08/2019 | Q1 2019 | -$0.75 | $0.30 | 1.05 | $2.69 M | |
| 03/01/2019 | Q4 2018 | -$0.90 | -$0.88 | 0.02 | $0 | |
| 11/13/2018 | Q3 2018 | -$1.20 | -$1.08 | 0.12 | $314,500 | |
| 08/03/2018 | Q2 2018 | -$2.10 | -$1.11 | 0.99 | $242,012 | |
| 05/11/2018 | Q1 2018 | -$3.60 | -$2.07 | 1.53 | $1.10 M | |
| 03/02/2018 | Q4 2017 | -$3.60 | -$2.47 | 1.13 | $0 | |
| 11/14/2017 | Q3 2017 | -$3.22 | -$3.61 | -0.39 | $74,696 | |
| 08/04/2017 | Q2 2017 | -$0.20 | -$4.14 | -3.94 | $148,290 | |
| 05/05/2017 | Q1 2017 | -$0.39 | -$4.19 | -3.8 | $184,532 |
EyeGate Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is EyeGate Pharmaceuticals, Inc.'s earnings date?
EyeGate Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 8th, 2021 based off last year's report dates.
-
How can I listen to EyeGate Pharmaceuticals, Inc.'s earnings conference call?
The conference call for EyeGate Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read EyeGate Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for EyeGate Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does EyeGate Pharmaceuticals, Inc. generate each year?
EyeGate Pharmaceuticals, Inc. (:EYEG) has a recorded annual revenue of $12,059.
-
How much profit does EyeGate Pharmaceuticals, Inc. generate each year?
EyeGate Pharmaceuticals, Inc. (:EYEG) has a recorded net income of $12,059. EyeGate Pharmaceuticals, Inc. has generated $-2.54 earnings per share over the last four quarters.
-
What is EyeGate Pharmaceuticals, Inc.'s price-to-earnings ratio?
EyeGate Pharmaceuticals, Inc. (:EYEG) has a price-to-earnings ratio of -14.53 and price/earnings-to-growth ratio is 1.05.
